Specialty pharmaceutical companies such as Turing and Valeant,which face criticism over soaring prices, are accused of greed at congressional hearingSpecialty pharmaceutical companies that acquire certain drugs then spike the prices “egregiously” were compared to loan sharks and warned they were putting patients “lives in the balance” at a congressional hearing on Wednesday.
Drug companies such as Turing and Valeant, and which absorb been under fire for months because of the soaring prices of lifesaving medications they made,were accused of being driven simply by greed, by congressional leaders in Washington on Wednesday afternoon.
Continue reading...
Source: theguardian.com